Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 736 of 1,261
  1. US 9120813

    Oxadiazoanthracene compounds for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  2. US 9119837

    Use of sEH inhibitors as analgesics

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  3. US 9119884

    LLP2A-bisphosphonate conjugates for osteoporosis treatment

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  4. US 9121852

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  5. US 9120811

    6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma

    GILEAD CONNECTICUT, INC. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  6. US 9120851

    Human antibodies to human angiopoietin-like protein 4

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  7. US 9120867

    Lutzomyia longipalpis polypeptides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  8. US 9120790

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  9. US 9120758

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  10. US 9120777

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  11. US 9120776

    Condensed heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  12. US 9120747

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  13. US 9120031

    Compositions of particulate coformulation

    Nektar Therapeutics · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  14. US 9120746

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  15. US 9120744

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  16. US 9119864

    Bioeffective krill oil compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  17. US 9119863

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  18. US 9119832

    Methods of treating mild brain injury

    The Regents of the University of California · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  19. US 9119828

    Antibodies with simultaneous subsite specificities to protein and lipid epitopes

    The United States of America as represented by the Secretary of the Army · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  20. US 9119823

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  21. US 9119792

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  22. US 9119773

    Toroidal pharmaceutical formulations

    The Board of Regents of the University of Texas System · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  23. US 9119791

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  24. US 9120967

    Concentric forster resonance energy transfer relay for the parallel detection of two bio/physicochemical process

    United States of America as represented by the Secretary of the Air Force · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.